Literature DB >> 8496694

Complement-mediated adipocyte lysis by nephritic factor sera.

P W Mathieson1, R Würzner, D B Oliveria, P J Lachmann, D K Peters.   

Abstract

Recent data indicate a previously unsuspected link between the complement system and adipocyte biology. Murine adipocytes produce key components of the alternative pathway of complement and are able to activate this pathway. This suggested to us an explanation for adipose tissue loss in partial lipodystrophy, a rare human condition usually associated with the immunoglobulin G(IgG) autoantibody nephritic factor (NeF) which leads to enhanced alternative pathway activation in vivo. We hypothesized that in the presence of NeF, there is dysregulated complement activation at the membrane of the adipocyte, leading to adipocyte lysis. Here we show that adipocytes explanted from rat epididymal fat pads are lysed by NeF-containing sera but not by control sera. A similar pattern is seen with IgG fractions of these sera. Adipocyte lysis in the presence of NeF is associated with the generation of fluid-phase terminal complement complexes, the level of which correlates closely with the level of lactate dehydrogenase, a marker of cell lysis. Lysis is abolished by ethylenediaminetetraacetic acid, which chelates divalent cations and prevents complement activation, and reduced by an antibody to factor D, a key component of the alternative pathway. These data provide an explanation for the previously obscure link between NeF and fat cell damage.

Entities:  

Mesh:

Substances:

Year:  1993        PMID: 8496694      PMCID: PMC2191037          DOI: 10.1084/jem.177.6.1827

Source DB:  PubMed          Journal:  J Exp Med        ISSN: 0022-1007            Impact factor:   14.307


  17 in total

Review 1.  THE SYNDROMES OF TOTAL LIPODYSTROPHY AND OF PARTIAL LIPODYSTROPHY.

Authors:  B SENIOR; S S GELLIS
Journal:  Pediatrics       Date:  1964-04       Impact factor: 7.124

2.  A monoclonal antibody which blocks the function of factor D of human complement.

Authors:  M Pascual; E Catana; F Spertini; K Macon; J E Volanakis; J A Schifferli
Journal:  J Immunol Methods       Date:  1990-03-09       Impact factor: 2.303

Review 3.  Activation-dependent epitopes in the terminal complement pathway.

Authors:  T E Mollnes; T Lea; J Tschopp
Journal:  Complement Inflamm       Date:  1989

4.  Serum C'3 lytic system in patients with glomerulonephritis.

Authors:  R E Spitzer; E H Vallota; J Forristal; E Sudora; A Stitzel; N C Davis; C D West
Journal:  Science       Date:  1969-04-25       Impact factor: 47.728

5.  The activation of specific gene transcription in the adipose conversion of 3T3 cells.

Authors:  P Djian; M Phillips; H Green
Journal:  J Cell Physiol       Date:  1985-09       Impact factor: 6.384

6.  Adipsin and complement factor D activity: an immune-related defect in obesity.

Authors:  B S Rosen; K S Cook; J Yaglom; D L Groves; J E Volanakis; D Damm; T White; B M Spiegelman
Journal:  Science       Date:  1989-06-23       Impact factor: 47.728

7.  The complement abnormalities of lipodystrophy.

Authors:  J G Sissons; R J West; J Fallows; D G Williams; B J Boucher; N Amos; D K Peters
Journal:  N Engl J Med       Date:  1976-02-26       Impact factor: 91.245

8.  C3 nephritic factor (C3NeF): stabilization of fluid phase and cell-bound alternative pathway convertase.

Authors:  M R Daha; D T Fearon; K F Austen
Journal:  J Immunol       Date:  1976-01       Impact factor: 5.422

9.  Severely impaired adipsin expression in genetic and acquired obesity.

Authors:  J S Flier; K S Cook; P Usher; B M Spiegelman
Journal:  Science       Date:  1987-07-24       Impact factor: 47.728

10.  Complete and partial deficiencies of complement factor D in a Dutch family.

Authors:  P S Hiemstra; E Langeler; B Compier; Y Keepers; P C Leijh; M T van den Barselaar; D Overbosch; M R Daha
Journal:  J Clin Invest       Date:  1989-12       Impact factor: 14.808

View more
  21 in total

1.  Partial lipodystrophy, polycystic ovary syndrome and proteinuria: a common link to insulin resistance?

Authors:  V C Blackwell; P Salis; R W Groves; S E Baldeweg; G S Conway; R J Unwin
Journal:  J R Soc Med       Date:  2001-05       Impact factor: 5.344

Review 2.  The role of complement system in adipose tissue-related inflammation.

Authors:  Sonia I Vlaicu; Alexandru Tatomir; Dallas Boodhoo; Stefan Vesa; Petru A Mircea; Horea Rus
Journal:  Immunol Res       Date:  2016-06       Impact factor: 2.829

Review 3.  C3 Glomerulopathy.

Authors:  Magdalena Riedl; Paul Thorner; Christoph Licht
Journal:  Pediatr Nephrol       Date:  2016-04-07       Impact factor: 3.714

Review 4.  Exploring the pathophysiology behind the more common genetic and acquired lipodystrophies.

Authors:  Tom Nolis
Journal:  J Hum Genet       Date:  2013-10-24       Impact factor: 3.172

5.  Candida albicans Hgt1p, a multifunctional evasion molecule: complement inhibitor, CR3 analogue, and human immunodeficiency virus-binding molecule.

Authors:  Iwona Lesiak-Markowicz; Georgia Vogl; Tobias Schwarzmüller; Cornelia Speth; Cornelia Lass-Flörl; Manfred P Dierich; Karl Kuchler; Reinhard Würzner
Journal:  J Infect Dis       Date:  2011-09-01       Impact factor: 5.226

Review 6.  Partial lipodystrophy, mesangiocapillary glomerulonephritis, and complement dysregulation. An autoimmune phenomenon.

Authors:  Y Levy; J George; E Yona; Y Shoenfeld
Journal:  Immunol Res       Date:  1998-08       Impact factor: 2.829

Review 7.  Translational mini-review series on complement factor H: therapies of renal diseases associated with complement factor H abnormalities: atypical haemolytic uraemic syndrome and membranoproliferative glomerulonephritis.

Authors:  M Noris; G Remuzzi
Journal:  Clin Exp Immunol       Date:  2007-12-07       Impact factor: 4.330

8.  Long-term fundus changes in acquired partial lipodystrophy.

Authors:  Joyce Jansen; Lien Delaere; Leigh Spielberg; Anita Leys
Journal:  BMJ Case Rep       Date:  2013-11-18

9.  Characterization of a factor H mutation that perturbs the alternative pathway of complement in a family with membranoproliferative GN.

Authors:  Edwin K S Wong; Holly E Anderson; Andrew P Herbert; Rachel C Challis; Paul Brown; Geisilaine S Reis; James O Tellez; Lisa Strain; Nicholas Fluck; Ann Humphrey; Alison Macleod; Anna Richards; Daniel Ahlert; Mauro Santibanez-Koref; Paul N Barlow; Kevin J Marchbank; Claire L Harris; Timothy H J Goodship; David Kavanagh
Journal:  J Am Soc Nephrol       Date:  2014-04-10       Impact factor: 10.121

Review 10.  Navigating the maze of complement genetics: a guide for clinicians.

Authors:  Harvey R Colten
Journal:  Curr Allergy Asthma Rep       Date:  2002-09       Impact factor: 4.919

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.